Tokyo, Japan

Hiroyasu Onaka

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Tokyo. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyasu Onaka. Retrieved from https://idiyas.com/inventor/hiroyasu-onaka-ici9c327

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroyasu Onaka: Innovator in Compound Library Production

Introduction

Hiroyasu Onaka is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of compound libraries, which are essential for various applications in drug discovery and development. His innovative approach has led to the creation of a unique method for producing cyclic compounds.

Latest Patents

Hiroyasu Onaka holds a patent for a "Compound library and method for producing compound library." This invention provides a method for producing a compound library comprising two or more cyclic compounds. The method involves allowing a macrocyclase in vitro to act on two or more peptides, resulting in the formation of nitrogen-containing 6-membered rings.

Career Highlights

Onaka is affiliated with The University of Tokyo, where he continues to advance research in the field of compound libraries. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology.

Collaborations

Hiroyasu Onaka has collaborated with notable researchers, including Hiroaki Suga and Yuki Goto. These partnerships have further enriched his research and contributed to advancements in the field.

Conclusion

Hiroyasu Onaka's innovative work in the production of compound libraries exemplifies the importance of research in drug development. His contributions are paving the way for future advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…